Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl


Preferences help
enabled [disable] Abstract
Number of results
2000 | 48 | 1 | 39-42

Article title

Abnormal distribution of gamma delta T lymphocytes in Graves' disease and insulin-dependent diabetes type

Title variants

Languages of publication



There is an increasing evidence that CD3+ cells, bearing gamma delta T cell receptors representing a minor subpopulation of T cells in the peripheral blood of humans are involved in the development of autoimmunity. The aim of the present study was determination of the gamma delta T cell subpopulation levels in the peripheral blood of subjects with Graves' disease and newly diagnosed type 1 diabetes in comparison to age-matched healthy controls. The percentages of CD3+, CD8+, gamma delta TCR+CD8+, gamma delta TCR+CD8? lymphocyte subsets were measured by flow cytometry. In the peripheral blood of newly diagnosed Graves' disease patients we showed a significant decrease of gamma delta TCR+ cells and gamma delta TCR+CD8? subset content in comparison to the percentages observed in subjects after methimazole treatment and in healthy controls. We also found a significant increase of TCR+CD8+ cells in the peripheral blood of subjects with insulin-dependent diabetes, treated with insulin for 3?6 months. The present findings confirm our previous hypothesis that gamma deltaTCR+CD8+ lymphocyte subset could play a role in the pathogenesis of diabetes type 1, probably as regulatory T cells and could be induced by delivery of exogenous insulin. Our results suggest that gamma deltaT cells (gamma delta TCR+CD8? subset) could also play an important role in the development of Graves' disease and that their levels are modulated by thyreostatic treatment.




Document Type


Publication order reference

A. Kretowski, Department of Endocrinology, University Medical School, Bialystok, Poland


YADDA identifier

JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.